Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells

Oncology (Switzerland)

Volumn 54, Issue 2, 1997, Pages 153-157

  Hotta, Tsukasa ^a   Tanimura, Hiroshi ^a   Yamaue, Hiroki ^a   Iwahashi, Makoto ^a   Tani, Masaji ^a   Tsunoda, Takuya ^a   Tamai, Mikiko ^a   Noguchi, Kohei ^a   Mizobata, Shizuma ^a   Arii, Kazuo ^a   Terasawa, Hiroshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cepharanthine; Doxorubicin; Multidrug resistance; P glycoprotein

Indexed keywords

CEPHARANTHINE; DOXORUBICIN; GLYCOPROTEIN P;

ARTICLE; CANCER PATIENT; CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FLOW CYTOMETRY; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKALOIDS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; P-GLYCOPROTEIN; STOMACH NEOPLASMS;

EID: 0031054376     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227680     Document Type: Article

References (33)

1. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochcm 1993:62: 385-427.
2. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V: Amplification of P-glycopro-tein genes in multidrug-resistant mammalian cell lines, Nature 1985;316:817-819.
3. Roninson IB, Chin JE, Choi K, Gros P, Hous-man DE, Fojo A, Shen DW, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells, Proc Natl Acad Sci USA 1986; 83:4538-4542.
4. Shiraishi N, Akiyama S, Nakagawa M, Ko-bayashi M, Kuwano M: Effect of bisbenzyliso-quinoline(biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells, Cancer Res 1987;47:2413-2416.
5. Nagaoka S, Kawasaki S, Karino Y, Sasaki K, Nakanishi T: Modification of cellular efflux and cytotoxicity of Adriamycin by biscoclaulin alkaloid in vitro, Eur J Cancer 1987;23:1297-1302.
6. Akiyama S, Cornwell MM, Kuwano M, Pastan I, Gottesman MM: Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog, Mol Pharmacol 1987;33:144-147.
7. Akiyama S, Yoshimura A, Kikuchi H, Sumiza-wa T, Kuwano M, Tahara Y: Synthetic isopre-noid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells, Mol Pharmacol 1989;36:730-735.
8. Komiyama S, Matsui K, Kudoh S, Nogae I, Kuratomi Y, Saburi Y, Asoh K, Kohno K, Kuwano M: Establishment of tumor cell lines from a patient with head and neck canccr and their different sensitivities to anti-cancer agents, Cancer 1989;63:675-681.
9. Saito T, Hikita M, Kohno K, Sato S, Takano H, Kobayashi M: Different sensitivities of human esophageal canccr cells to multiple anti-cancer agents and related mechanisms, Cancer 1992; 70:2402-2409.
10. Carmichael J, Mitchell JB, Degraff WG, Gam-son J, Gazdar AF, Johnson BE, Glatstcin E, Minna JD: Chcmoscnsitivity testing of human lung cancer cell lines using the MTT assay, Br J Cancer 1985;57:540-547.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods 1983;65:55-63.
12. Twentyman PR, Fox NE, Rees JKH: Chemo-sensitivity testing of fresh leukaemia cells using the MTT colorimetric assay, Br J Haematol 1989;71:19-24.
13. Campling BJ, Pym J, Baker HM, Cole SPC, Lam YM: Chemosensitivity testing of small cell lung cancer using the MTT assay, Br J Cancer 1991;63:75-83.
14. Yamauc H, Tanimura H, Tsunoda T, Tani M, Iwahashi M, Noguchi K, Tamai M, Hotta T, Arii K: Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimctric assay, Eur J Cancer 1991; 27:1258-1263.
15. Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M, Iwakura S: Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay, Br J Canccr 1992;66:794-799.
16. Yamaue H, Tanimura H, Nakamori M, Noguchi K, Iwahashi M, Tani M, Hotta T, Murakami K, Ishimoto K: Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay, Dis Colon Rectum 1996;39:416-422.
17. Webb JL: Effect of more than one inhibitor; antagonism, summation, and synergism; in Webb JL (ed): Enzyme and Metabolic Inhibitors, New York, Acadcmic Press, 1963, vol I, pp 488-512.
18. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roc DJ, Miller TP: Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as chemosensitizer, Blood 1991;78:44-50.
19. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil, Cancer Res 1981;41:1967-1972.
20. Slater LM, Sweet P, Stupecky M, Gupta S: Cyclosporin A reverses vincristine and dauno-rubicin resistance in acute lymphatic leukemia in vitro, J Clin Invest 1986;77:1405-1408.
21. Yahanda AM, Adler KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI: Phase I trial of etoposidc with cyclosporine as a modulator of multidrug resistance, J Clin Oncol 1992;10:1624-1634.
22. Soto F, Planells-Cases R, Canaves JM, Ferrer-Montiel AV, Aleu J, Gamarro F, Castanys S, Gonzalez-Ros JM, Ferragut JA: Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells, Eur J Cancer 1993;29A: 2144-2150.
23. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors and tissues, Proc Natl Acad Sci USA 1987;84:265-269.
24. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottes-mar, MM, Pastan I: Expression of a multidrug resistance gene in human cancers, J Natl Cancer Inst 1989;81:116-124.
25. Clifford SC, Thomas DJ, Neal DE, Lunec J: Increased mdrl gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay, Br J Cancer 1994;69:680-686.
26. Volm M, Mattern J, Samscl B: Overexpression of P-glycoprotein and glutathione S-transfer-ase-T in resistant non-small cell lung carcinomas of smokers, Br J Cancer 1991,64:700-704.
27. Yamauchi M, Kumazawa H, Satta T, Sugawa-ra I, Isobe K, Kodera Y, Ito K, Watanabe T, Takagi H: Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotcin staining, Eur J Cancer 1992;28A:1422-1427.
28. Kartner N, Evemden-Porelle D, Bradley G, Ling V: Detection of P-glycoprotcin in multidrug-resistant cell lines by monoclonal anti-bod:cs, Nature 1985;316:820-823.
29. Leonce S, Pierre A, Anstett M, Perez V, Gen-ton A, Bizzari JP, Atassi G: Effects of a new triazinoaminopipcridine derivative on Adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance, Biochem Pharmacol 1992,44:1707-1715.
30. Thierry AR, Jorgensen TJ, Forst D, Belli JA, Dritschilo A, Rahman A: Multidrug resistance in Chinese hamster cells: Effect of liposome-encapsulated doxorubicin, Cancer Commun 1989;1:311-316.
31. Tamai M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, Noguchi K, Mizobata S, Hotta T, Arii K, Terasawa H: Clinical significance of quantitative analysis of carcinoem-bryonic antigen assessed by flow cytometry in fresh human gastric cancer cells, Cancer Lett 1995;90:111-117.
32. Schinkel AH, Roelofs MEM, Borst P: Characterization of the human MDR3 P-glycoprotcin and its recognition by P-glycoprotein-spccific monoclonal antibodies, Canccr Res 1991:51: 2628-2635.
33. Chatterjee M, Harris AL: Reversal of acquired resistance to Adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: Role of drug interaction with alpha 1 acid glycoprotein, Br J Cancer 1990:62:712-717.